loxoprofen has been researched along with Heart Failure in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, Y | 1 |
Yasumizu, R | 1 |
Hashimoto, F | 1 |
Otsuka, Y | 1 |
Okamura, A | 1 |
Kato, Y | 1 |
Oyaizu, H | 1 |
Ikebukuro, K | 1 |
Fukuhara, S | 1 |
Nakai, Y | 1 |
Ikehara, S | 1 |
1 other study available for loxoprofen and Heart Failure
Article | Year |
---|---|
An autopsy case of giant cell myocarditis probably due to a non-steroidal anti-inflammatory drug.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocyt | 2001 |